{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:04Z","timestamp":1761893584450,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1023\/a:1010639332737","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T03:31:49Z","timestamp":1040614309000},"page":"155-160","source":"Crossref","is-referenced-by-count":29,"title":["Genetic thrombophilia in patients with retinal vascular occlusion"],"prefix":"10.1007","volume":"23","author":[{"given":"Kathrin","family":"Greiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Peetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Winkgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"Prellwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"321256_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0038-1635488","volume":"26","author":"K. Abt","year":"1987","unstructured":"Abt K. Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Methods Inf Med 1987; 26: 77\u201388.","journal-title":"Methods Inf Med"},{"key":"321256_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/00313029700169285","volume":"29","author":"RD Appleby","year":"1997","unstructured":"Appleby RD, Olds RJ. The inherited basis of venous thrombosis. Pathology 1997; 29: 341\u20137.","journal-title":"Pathology"},{"key":"321256_CR3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1055\/s-0038-1665428","volume":"78","author":"VR Arruda","year":"1997","unstructured":"Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430\u20133.","journal-title":"Thromb Haemost"},{"key":"321256_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1648808","volume":"72","author":"F Bandello","year":"1994","unstructured":"Bandello F, Vigano DS, Parlavecchia M, Tavola A, Della VP, Brancato R et al. Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994; 72: 39\u201343.","journal-title":"Thromb Haemost"},{"key":"321256_CR5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de RH, van-der VP, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64\u20137.","journal-title":"Nature"},{"key":"321256_CR6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1056\/NEJM199806183382510","volume":"338","author":"RM Bertina","year":"1998","unstructured":"Bertina RM, Rosendaal FR. Venous thrombosis- the interaction of genes and environment. N Engl J Med 1998; 338: 1840\u20131.","journal-title":"N Engl J Med"},{"key":"321256_CR7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0038-1665404","volume":"75","author":"LC Chan","year":"1996","unstructured":"Chan LC, Bourke C, Lam CK, Liu HW, Brookes S, Jenkins V et al. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors- correlation with absence of Arg506-Gln mutation of factor V gene. Thromb Haemost 1996; 75: 522\u20133.","journal-title":"Thromb Haemost"},{"key":"321256_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/joim.1997.242.s740.1","volume":"740","author":"B. Dahlb\u00e4ck","year":"1997","unstructured":"Dahlb\u00e4ck B. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med Suppl 1997; 740: 1\u20138.","journal-title":"J Intern Med Suppl"},{"key":"321256_CR9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","volume":"90","author":"B Dahlb\u00e4ck","year":"1993","unstructured":"Dahlb\u00e4ck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"321256_CR10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00001721-199507000-00013","volume":"6","author":"F. Demarmels-Biasiutti","year":"1995","unstructured":"Demarmels-Biasiutti F., Merlo C, Furlan M, Sulzer I, Binder BR, Lammle B. No association of APC resistance with myocardial infarction. Blood Coagul Fibrinolysis 1995; 6: 456\u20139.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"321256_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/112067219300300301","volume":"3","author":"PM Dodson","year":"1993","unstructured":"Dodson PM, Clough CG, Downes SM, Kritzinger EE. Does type II diabetes predispose to retinal vein occlusion? Eur J Ophthalmol 1993; 3: 109\u201313.","journal-title":"Eur J Ophthalmol"},{"key":"321256_CR12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1055\/s-0038-1649946","volume":"74","author":"H Fujimura","year":"1995","unstructured":"Fujimura H, Kambayash J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 1995; 74: 1381\u20132.","journal-title":"Thromb Haemost"},{"key":"321256_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archopht.117.1.43","volume":"117","author":"CJ Glueck","year":"1999","unstructured":"Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999; 117: 43\u20139.","journal-title":"Arch Ophthalmol"},{"key":"321256_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2796.1997.139145000.x","volume":"241","author":"P Hainaut","year":"1997","unstructured":"Hainaut P, Azerad MA, Lehmann E, Schlit AF, Zech F, Heusterspreute M et al. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. J Intern Med 1997; 241: 427\u201333.","journal-title":"J Intern Med"},{"key":"321256_CR15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1055\/s-0038-1657674","volume":"78","author":"A Hillarp","year":"1997","unstructured":"Hillarp A, Zoller B, Svensson PJ, Dahlb\u00e4ck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990\u20132.","journal-title":"Thromb Haemost"},{"key":"321256_CR16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/eye.1995.191","volume":"9","author":"PR Hodgkins","year":"1995","unstructured":"Hodgkins PR, Perry DJ, Sawcer SJ, Keast BJ. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye 1995; 9: 760\u20132.","journal-title":"Eye"},{"key":"321256_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9394(98)00226-8","volume":"126","author":"H Iijima","year":"1998","unstructured":"Iijima H, Gohdo T, Imai M, Tsukahara S. Thrombinantithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol 1998; 126: 677\u201382.","journal-title":"Am J Ophthalmol"},{"key":"321256_CR18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0140-6736(94)90673-4","volume":"344","author":"JI Jorquera","year":"1994","unstructured":"Jorquera JI, Montoro JM, Fernandez MA, Aznar JA. Modi-fied test for activated protein C resistance. Lancet 1994; 344: 1162\u20133.","journal-title":"Lancet"},{"key":"321256_CR19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-0038-1653820","volume":"73","author":"K Kontula","year":"1995","unstructured":"Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen MR, Hamalainen L et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995; 73: 558\u201360.","journal-title":"Thromb Haemost"},{"key":"321256_CR20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","volume":"342","author":"T Koster","year":"1993","unstructured":"Koster T, Rosendaal FR, de RH, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503\u20136.","journal-title":"Lancet"},{"key":"321256_CR21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1650638","volume":"76","author":"DA Lane","year":"1996","unstructured":"Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996a; 76: 651\u201362.","journal-title":"Thromb Haemost"},{"key":"321256_CR22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1055\/s-0038-1650673","volume":"76","author":"DA Lane","year":"1996","unstructured":"Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V et al. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 824\u201334.","journal-title":"Thromb Haemost"},{"key":"321256_CR23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/bjo.80.3.200","volume":"80","author":"J Larsson","year":"1996","unstructured":"Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996; 80: 200\u20132.","journal-title":"Br J Ophthalmol"},{"key":"321256_CR24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(94)90035-3","volume":"343","author":"B Lindblad","year":"1994","unstructured":"Lindblad B, Svensson PJ, Dahlb\u00e4ck B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994; 343: 917.","journal-title":"Lancet"},{"key":"321256_CR25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0038-1655933","volume":"77","author":"T Linna","year":"1997","unstructured":"Linna T, Ylikorkala A, Kontula K, Puska P, Tervo T. Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 1997; 77: 214\u20136.","journal-title":"Thromb Haemost"},{"key":"321256_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/joim.1997.242.s740.9","volume":"Suppl740","author":"M Makris","year":"1997","unstructured":"Makris M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk factors and management. J Intern Med 1997; Suppl 740: 9\u201315.","journal-title":"J Intern Med"},{"key":"321256_CR27","first-page":"377","volume":"83","author":"C Marzo","year":"1998","unstructured":"Marzo C, Araguas C, Gomez AJ, Ramirez S. Prevalence of phenotypic activated protein C resistance (APCR) in venous thromboembolic patients. Haematologica 1998; 83: 377\u20138.","journal-title":"Haematologica"},{"key":"321256_CR28","first-page":"378","volume":"83","author":"T Olave","year":"1998","unstructured":"Olave T, Cornudella R, Homs C, Azaceta G, Tirado I, Gutierrez M. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain. Haematologica 1998; 83: 378\u201380.","journal-title":"Haematologica"},{"key":"321256_CR29","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698\u2013703.","journal-title":"Blood"},{"key":"321256_CR30","first-page":"460","volume":"25","author":"O Raguenes","year":"1996","unstructured":"Raguenes O, Mercier B, Escoffre M, Traore L, Blouch MT, Robinet A et al. 1691 G to A mutation of the factor V gene: no association with thrombosis of the central retinal vein. Presse Med 1996; 25: 460.","journal-title":"Presse Med"},{"key":"321256_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0161-6420(92)31940-2","volume":"99","author":"EZ Rath","year":"1992","unstructured":"Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 1992; 99: 509\u201314.","journal-title":"Ophthalmology"},{"key":"321256_CR32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","volume":"346","author":"DC Rees","year":"1995","unstructured":"Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133\u20134.","journal-title":"Lancet"},{"key":"321256_CR33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","volume":"332","author":"PM Ridker","year":"1995","unstructured":"Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912\u20137.","journal-title":"N Engl J Med"},{"key":"321256_CR34","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","volume":"89","author":"FR Rosendaal","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth-WT J, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89: 2817\u201321.","journal-title":"Blood"},{"key":"321256_CR35","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0140-6736(94)90495-2","volume":"344","author":"NJ Samani","year":"1994","unstructured":"Samani NJ, Lodwick D, Martin D, Kimber P. Resistance to activated protein C and risk of premature myocardial infarction. Lancet 1994; 344: 1709\u201310.","journal-title":"Lancet"},{"key":"321256_CR36","first-page":"233","volume":"26","author":"W Schr\u00f6der","year":"1996","unstructured":"Schr\u00f6der W, Koesling M, Wulff K, Wehnert M, Herrmann FH. Large-scale screening for factor V Leiden mutation in a northeastern German population. Haemostasis 1996; 26: 233\u20136.","journal-title":"Haemostasis"},{"key":"321256_CR37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2307\/2529991","volume":"36","author":"HK Ury","year":"1980","unstructured":"Ury HK, Fleiss JL. On approximate sample sizes for comparing two independent proportions with the use of Yates\u2019 correction. Biometrics 1980; 36: 347\u201351.","journal-title":"Biometrics"},{"key":"321256_CR38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0038-1657602","volume":"78","author":"FJ van-der Meer","year":"1997","unstructured":"van-der Meer FJ, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631\u20135.","journal-title":"Thromb Haemost"},{"key":"321256_CR39","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","volume":"344","author":"JP Vandenbroucke","year":"1994","unstructured":"Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453\u20137.","journal-title":"Lancet"},{"key":"321256_CR40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0039-6257(93)90011-U","volume":"37","author":"AK Vine","year":"1993","unstructured":"Vine AK, Samama MM. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1993; 37: 283\u201392.","journal-title":"Surv Ophthalmol"},{"key":"321256_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bjo.80.3.203","volume":"80","author":"TH Williamson","year":"1996","unstructured":"Williamson TH, Rumley A, Lowe GD. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996; 80: 203\u20138.","journal-title":"Br J Ophthalmol"},{"key":"321256_CR42","first-page":"1815","volume":"38","author":"I. Witt","year":"1998","unstructured":"Witt I. APC-Resistenz (Faktor-V-Mutation). Klinische Bedeutung, Pathophysiologie und Diagnostik. Deutsches \u00c4rzteblatt 1998; 38: 1815\u201320.","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"321256_CR43","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0161-6420(79)35327-1","volume":"86","author":"H Zegarra","year":"1979","unstructured":"Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979; 86: 1931\u201342.","journal-title":"Ophthalmology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010639332737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1010639332737\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010639332737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T13:22:05Z","timestamp":1748352125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1010639332737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["321256"],"URL":"https:\/\/doi.org\/10.1023\/a:1010639332737","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}